BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
TZID:Europe/Helsinki
X-WR-TIMEZONE:Europe/Helsinki
BEGIN:VEVENT
UID:60@inflames.utu.fi
DTSTART;TZID=Europe/Helsinki:20211123T140000
DTEND;TZID=Europe/Helsinki:20211123T150000
DTSTAMP:20230120T083220Z
URL:https://inflames.utu.fi/events/type-1-diabetes-prediction-and-preventi
 on-dipp-study-what-have-we-learned/
SUMMARY:Immunology Seminar Series | Type 1 Diabetes Prediction and Preventi
 on (DIPP) Study - what have we learned?
DESCRIPTION:Virtual event\n\nRiitta Veijola\, University of Oulu and Oulu U
 niversity Hospital\nType 1 Diabetes Prediction and Prevention (DIPP)\n\nHo
 st: Riitta Lahesmaa (rilahes@utu.fi)\n\nRegister latest November 22nd at:\
 nhttps://link.webropolsurveys.com/S/1810BF8DB7BFF08D\n\nZoom link and iCal
 endar invitation to join the online event will be sent to all registered p
 articipants one day before the event.\n\nImmunology seminar series is join
 tly organised by the Finnish Society for Immunology\, InFLAMES Flagship an
 d Turku Bioscience. For further information contact Anne Lahdenperä (anka
 hy@utu.fi) or Riitta Lahesmaa (rilahes@utu.fi)\, University of Turku.\n\n.
 \n\nDr. Riitta Veijola is Professor of  Pediatrics at the University of O
 ulu and Oulu University Hospital.  She has basic clinical training in ped
 iatrics and pediatric endocrinology and has a strong track record in type 
 1 diabetes research. She received her medical degree (1985) and PhD degree
  (1996) at the University of Oulu\, after which she did her specialty degr
 ee in Pediatric Endocrinology.\n\nSince 2001\, Riitta Veijola has been res
 ponsible for the Finnish Type 1 Diabetes Prediction and Prevention (DIPP) 
 Study\, which is an ongoing large prospective study at three university ho
 spitals (Turku\, Oulu and Tampere)  in Finland since 1994. The DIPP study
  currently has appr. 6000 children aged 0-15 years in Finland. Together wi
 th the researchers in the DIPP Study Riitta Veijola has published more tha
 n 200 papers on genetics\, prediction and pathogenesis of type 1 diabetes.
 \n\nSelected publications:\n\n 	Anand V\, Li Y\, Liu B\, Ghalwash M\, Kosk
 i E\, Ng K\, Dunne JL\, Jönsson J\, Winkler C\, Knip M\, Toppari J\, Ilon
 en J\, Killian MB\, Frohnert BI\, Lundgren M\, Ziegler AG\, Hagopian W\, V
 eijola R\, Rewers M\; T1DI Study Group. Islet Autoimmunity and HLA Markers
  of Presymptomatic and Clinical Type 1 Diabetes: Joint Analyses of Prospec
 tive Cohort Studies in Finland\, Germany\, Sweden\, and the U.S. Diabetes 
 Care 2021 Jun 23:dc201836. doi: 10.2337/dc20-1836. Epub ahead of print. PM
 ID: 34162665.\n 	Ilonen J\, Lempainen J\, Veijola R. The heterogeneous pat
 hogenesis of type 1 diabetes mellitus. Nat Rev Endocrinol 2019\;15:635-650
 . doi:10.1038/s41574-019-0254-y.\n 	Koskinen MK\, Lempainen J\, Löyttynie
 mi E\, Helminen O\, Hekkala A\, Härkönen T\, Kiviniemi M\, Simell O\, Kn
 ip M\, Ilonen J\, Toppari J\, Veijola R. Class II HLA Genotype Association
  with First Phase Insulin Response Is Explained by Islet Autoantibodies. J
  Clin Endocrinol Metab 2018 Aug 1\;103(8):2870-2878. doi: 10.1210/jc.2017-
 02040.\n\n&nbsp\;
END:VEVENT
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
X-LIC-LOCATION:Europe/Helsinki
BEGIN:STANDARD
DTSTART:20211031T030000
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
END:STANDARD
END:VTIMEZONE
END:VCALENDAR